Biotechnology startup

Spirox

Spirox is a medical device company improving the quality of life for patients suffering from nasal obstruction.

Funding reportedLast round: Series C

Biotechnology

What company datasets say Spirox raised

Funding, as reported

Reported in all71.5Min the source's currency
Rounds4
Last roundSeries C
Last round dateMar 2016
Investors listed8

On a portfolio page

Investors who name them

Each firm lists Spirox on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Spirox in front of investors. Or tell us what we have wrong.